Item 7.01 Regulation FD Disclosure.

On May 14, 2020, Capricor Therapeutics, Inc., a Delaware corporation (the "Company"), provided an update in the form of a slide presentation during its quarterly earnings call. The slide presentation is located on the "Investors" section of the Company's website at www.capricor.com. A copy of the slide presentation is also attached hereto as Exhibit 99.1 and is incorporated by reference into this Item 7.01 of this Current Report on Form 8-K.

The information contained in this Form 8-K (including Exhibit 99.1 attached hereto) is being furnished and shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section and shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.





(d) Exhibits

99.1 Capricor Therapeutics, Inc. slide presentation dated May 14, 2020.

© Edgar Online, source Glimpses